Articles by Licensed Peptides
Cell-Penetrating Peptides and the JNK Pathway in Neurodegeneration Research
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Developing treatments for neurodegenerative disorders presents a major challenge, largely due to the limited capacity of most therapeutic...
AmyP53 in Alzheimer’s and Parkinson’s Disease Research Models
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Alzheimer’s disease (AD) and Parkinson’s disease (PD) are progressive neurodegenerative disorders characterized by protein misfolding and abnormal aggregation....
Neuroprotective Effects of Fraternine on Motor Neurons in Parkinson’s Disease Models
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Parkinson’s disease (PD) is a progressive neurodegenerative disorder that currently affects approximately one million individuals in the United...
Cdk5i in Alzheimer’s Disease Research Models
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background Cyclin-dependent kinase 5 (Cdk5) is a neuronal kinase activated by p35 and p39 cofactors. Under physiological conditions, Cdk5...
V24P Variant in Alzheimer’s Disease Research Models
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background on Amyloid Pathogenesis in Alzheimer’s Disease Alzheimer’s disease (AD) has long been associated with the accumulation of amyloid-β...
Stay Ahead of the Curve
Get exclusive updates on events, promotions, and special offers.